Hepatitis B surface antigen (HBsAg) prevalence (%) in Equatorial Guinea
Equatorial Guinea: Hepatitis B surface antigen (HBsAg) prevalence was 2.0% in 2024. ▼ Falling
Latest (2024)
2.0%
Change on year
unchanged
World rank
12th
of 194 countries
All-time high
2.4%
in 2015
All-time low
2.0%
in 2023
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Equatorial Guinea, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Equatorial Guinea stood at 2.0%. That is the lowest value across all 10 years on record.
That represents a change of down 16.7% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Equatorial Guinea peaked at 2.4% in 2015 and was at its lowest, 2.0%, in 2023.
Equatorial Guinea ranks 12th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Equatorial Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.4% | — |
| 2016 | 2.3% | -4.2% |
| 2017 | 2.3% | +0.0% |
| 2018 | 2.3% | +0.0% |
| 2019 | 2.2% | -4.3% |
| 2020 | 2.2% | +0.0% |
| 2021 | 2.2% | +0.0% |
| 2022 | 2.1% | -4.5% |
| 2023 | 2.0% | -4.8% |
| 2024 | 2.0% | +0.0% |
Equatorial Guinea compared with similar countries
- Equatorial Guinea's 2.0% is above the median for upper middle income countries, which is 0.2%, 10.0× the median. (57 countries reporting)
- Equatorial Guinea's 2.0% is above the median for Sub-Saharan Africa, which is 1.1%, 1.9× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.3% | 2.2% | 2.4% | 5 |
| 2020s | 2.1% | 2.0% | 2.2% | 5 |
Countries ranked near Equatorial Guinea
More health data for Equatorial Guinea
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.06 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 863.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 843 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 5 (2025)
- Population ages 00-04, female, annual growth rate 1.5 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.66 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Equatorial Guinea?
- Hepatitis b surface antigen (hbsag) prevalence in Equatorial Guinea was 2.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Equatorial Guinea?
- The highest recorded value was 2.4% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Equatorial Guinea?
- The lowest recorded value was 2.0% in 2023.
- How does Equatorial Guinea rank for hepatitis b surface antigen (hbsag) prevalence?
- Equatorial Guinea ranks 12th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Equatorial Guinea?
- Over the last ten years it is down 16.7%. The long-run trend across the full record is falling.
- Where does this Equatorial Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).